FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2697151012> ?p ?o ?g. }

• W2697151012 endingPage "e0179927" @default.
• W2697151012 startingPage "e0179927" @default.
• W2697151012 abstract "Although the favourable characteristics of escitalopram as being the most selective serotonin reuptake inhibitor and having an increased therapeutic efficacy via binding on an additional allosteric binding site of the serotonin transporter, its dosing regimen has not yet been optimized for its use in dogs. This study aimed to estimate the optimal dosing frequency and the required dose for achieving 80% occupancy of the serotonin transporters in the basal ganglia. The dosing frequency was investigated by determining the elimination half-life after a four day oral pre-treatment period with 0.83 mg/kg escitalopram (3 administrations/day) and a subsequent i.v. injection 0.83 mg/kg. Blood samples were taken up to 12 hours after i.v. injection and the concentration of escitalopram in plasma was analysed via LC-MSMS. The dose-occupancy relationship was then determined by performing two PET scans in five adult beagles: a baseline PET scan and a second scan after steady state conditions were achieved following oral treatment with a specific dose of escitalopram ranging from 0.5 to 2.5 mg/kg/day. As the elimination half-life was determined to be 6.7 hours a dosing frequency of three administrations a day was proposed for the second part of the study. Further it was opted for a treatment period of four days, which well exceeded the minimum period to achieve steady state conditions. The optimal dosing regimen to achieve 80% occupancy in the basal ganglia and elicit a therapeutic effect, was calculated to be 1.85 mg/kg/day, divided over three administrations. Under several circumstances, such as insufficient response to other SSRIs, concurrent drug intake or in research studies focused on SERT, the use of escitalopram can be preferred over the use of the already for veterinary use registered fluoxetine, however, in case of long-term treatment with escitalopram, regularly cardiac screening is recommended." @default.
• W2697151012 created "2017-06-30" @default.
• W2697151012 creator A5002335988 @default.
• W2697151012 creator A5018373474 @default.
• W2697151012 creator A5024414034 @default.
• W2697151012 creator A5026672890 @default.
• W2697151012 creator A5029982164 @default.
• W2697151012 creator A5031507817 @default.
• W2697151012 creator A5043883257 @default.
• W2697151012 creator A5045890136 @default.
• W2697151012 creator A5049349696 @default.
• W2697151012 creator A5055319538 @default.
• W2697151012 creator A5078219843 @default.
• W2697151012 creator A5087926979 @default.
• W2697151012 date "2017-06-23" @default.
• W2697151012 modified "2023-10-12" @default.
• W2697151012 title "Estimation of the optimal dosing regimen of escitalopram in dogs: A dose occupancy study with [11C]DASB" @default.
• W2697151012 cites W1884477691 @default.
• W2697151012 cites W1965528390 @default.
• W2697151012 cites W1968750944 @default.
• W2697151012 cites W1986777050 @default.
• W2697151012 cites W1987226540 @default.
• W2697151012 cites W1987515571 @default.
• W2697151012 cites W1993067969 @default.
• W2697151012 cites W2008476241 @default.
• W2697151012 cites W2059759771 @default.
• W2697151012 cites W2074909493 @default.
• W2697151012 cites W2089348163 @default.
• W2697151012 cites W2094373637 @default.
• W2697151012 cites W2129633806 @default.
• W2697151012 cites W2141630824 @default.
• W2697151012 cites W2153538501 @default.
• W2697151012 cites W2155595217 @default.
• W2697151012 cites W2203826878 @default.
• W2697151012 cites W2272004162 @default.
• W2697151012 doi "https://doi.org/10.1371/journal.pone.0179927" @default.
• W2697151012 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5482480" @default.
• W2697151012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28644875" @default.
• W2697151012 hasPublicationYear "2017" @default.
• W2697151012 type Work @default.
• W2697151012 sameAs 2697151012 @default.
• W2697151012 citedByCount "4" @default.
• W2697151012 countsByYear W26971510122017 @default.
• W2697151012 countsByYear W26971510122021 @default.
• W2697151012 countsByYear W26971510122022 @default.
• W2697151012 crossrefType "journal-article" @default.
• W2697151012 hasAuthorship W2697151012A5002335988 @default.
• W2697151012 hasAuthorship W2697151012A5018373474 @default.
• W2697151012 hasAuthorship W2697151012A5024414034 @default.
• W2697151012 hasAuthorship W2697151012A5026672890 @default.
• W2697151012 hasAuthorship W2697151012A5029982164 @default.
• W2697151012 hasAuthorship W2697151012A5031507817 @default.
• W2697151012 hasAuthorship W2697151012A5043883257 @default.
• W2697151012 hasAuthorship W2697151012A5045890136 @default.
• W2697151012 hasAuthorship W2697151012A5049349696 @default.
• W2697151012 hasAuthorship W2697151012A5055319538 @default.
• W2697151012 hasAuthorship W2697151012A5078219843 @default.
• W2697151012 hasAuthorship W2697151012A5087926979 @default.
• W2697151012 hasBestOaLocation W26971510121 @default.
• W2697151012 hasConcept C112705442 @default.
• W2697151012 hasConcept C126322002 @default.
• W2697151012 hasConcept C170493617 @default.
• W2697151012 hasConcept C2775864247 @default.
• W2697151012 hasConcept C2777288759 @default.
• W2697151012 hasConcept C2779177272 @default.
• W2697151012 hasConcept C2779583969 @default.
• W2697151012 hasConcept C2780092697 @default.
• W2697151012 hasConcept C2781161787 @default.
• W2697151012 hasConcept C2781413609 @default.
• W2697151012 hasConcept C31487548 @default.
• W2697151012 hasConcept C35294091 @default.
• W2697151012 hasConcept C42219234 @default.
• W2697151012 hasConcept C71924100 @default.
• W2697151012 hasConcept C98274493 @default.
• W2697151012 hasConceptScore W2697151012C112705442 @default.
• W2697151012 hasConceptScore W2697151012C126322002 @default.
• W2697151012 hasConceptScore W2697151012C170493617 @default.
• W2697151012 hasConceptScore W2697151012C2775864247 @default.
• W2697151012 hasConceptScore W2697151012C2777288759 @default.
• W2697151012 hasConceptScore W2697151012C2779177272 @default.
• W2697151012 hasConceptScore W2697151012C2779583969 @default.
• W2697151012 hasConceptScore W2697151012C2780092697 @default.
• W2697151012 hasConceptScore W2697151012C2781161787 @default.
• W2697151012 hasConceptScore W2697151012C2781413609 @default.
• W2697151012 hasConceptScore W2697151012C31487548 @default.
• W2697151012 hasConceptScore W2697151012C35294091 @default.
• W2697151012 hasConceptScore W2697151012C42219234 @default.
• W2697151012 hasConceptScore W2697151012C71924100 @default.
• W2697151012 hasConceptScore W2697151012C98274493 @default.
• W2697151012 hasIssue "6" @default.
• W2697151012 hasLocation W26971510121 @default.
• W2697151012 hasLocation W26971510122 @default.
• W2697151012 hasLocation W26971510123 @default.
• W2697151012 hasLocation W26971510124 @default.
• W2697151012 hasLocation W26971510125 @default.
• W2697151012 hasLocation W26971510126 @default.
• W2697151012 hasOpenAccess W2697151012 @default.
• W2697151012 hasPrimaryLocation W26971510121 @default.

• next